Furthermore, in diffuse large B cell lymphoma (DLBCL), miR-101 regulates cell apoptosis by targeting lysine demethylase 1A (KDM1A) and MAPK kinase 1 (MEK1). Here, MAP2K1 is linked to diffuse large B-cell lymphoma.